1Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature, 1997, 385:6400-6404.
2Feng L, Chen S, Garcia GE, et al.Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1: rapid communication.Kidney Int, 1999, 56: 612-620.
3Furuichi K, Wada T, Iwata Y, et al.Upregulation of fractalkine in human crescentic glomerulonephritis. Nephron,2001, 87: 314-320.
2[1]SHIKATA K,MAKINO H.Role of macrophages in the pathogenesis of diabetic nephropathy[J].Contrib Nephrol,2001,(134):46-54.
3[2]FURUTA T,SAITO T,OOTAKA T,et al.The role of macrophages in diabetic glomerulosclerosis[J].Am J Kidney Dis,1993,21(5):480-485.
4[4]KATO S,LUYCKX V A,OTS M,et al.Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats[J].Kidney Int,1999,56(3):1037-1048.
5[5]TASHIRO K,KOYANAGI I,SAITOH A,et al.Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8),and renal injuries in patients with type 2 diabetic nephropathy[J].J Clin Lab Anal,2002,16(1):1-4.
6[6]AMANN B,TINZMANN R,ANQELKORT B,et al.ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1[J].Diabetes Care,2003,26 (8):2421-2425.
7[7][No authors listed].Extracellular and intracellular mediators[J].Nephrol Dial Transplant,2005,20(S5):27-36.
8[9]YOKOZAWA T,NAKAGAWA T,WAKAKI K,et al.Animal model of diabetic nephropathy[J].Exp Toxic Pathol,2001,53(5):359-363.
9[10]KIKUCHI Y,IMAKIIRE T,HYODO T.Advanced glycation endproduct induces fractalkine gene upregulation in normal rat glomeruli[J].Nephrol Dial Transplant,2005,20 (12):2690-2696.
10[11]LEE F T,CAO Z,LONG D M,et al.Interactions between angiotensin Ⅱ and NF-κB dependent pathways in modulating infiltration in experimental diabetic nephropathy[J].J Am Soc Nephrol,2004、15 (8):2139-2151.
